Welcome to PsychU!

Managing Partial Response: Augmentation Strategies In MDD

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Managing Partial Response: Augmentation Strategies In MDD

Persistent residual symptoms (e.g., sleep disturbances, cognitive symptoms) have known interference on quality of life and functioning of individuals with major depressive disorder (MDD) who respond to or remit from antidepressant treatment.1 Understanding the inherent challenges in symptom recognition and subsequent treatment, clinicians are tasked with finding optimal symptom relief in aiding patients on their journey towards functional recovery.

In this webinar, Dr. Alex Matushek moderates an enlightening discussion on the current state of clinical guidelines in the treatment framework of depression partial response management with Dr. Roueen Rafeyan. They will reflect on recent meta-analyses and current practice guidelines highlighting the optimization of pharmacotherapy to improve outcomes. Join us for this unique opportunity to learn and grow as we all strive to improve the quality of life of those impacted!

References:
1. Zajecka J, et al. Residual Symptoms in Major Depressive Disorder: Prevalence, Effects, and
Management. J Clin Psychiatry. 2013;74(4): 407-414.

Featuring

Roueen -Rafeyan

Roueen Rafeyan, MD

Psychiatrist & Chief Medical Officer for Gateway Foundation Addiction Treatment Centers and an Assistant Professor of Psychiatry at the Feinberg School of Medicine, Northwestern University

More
Roueen Rafeyan, MD has been a trailblazer in the field of Addiction Medicine for over 20 years, having served as a medical director for psychiatric and substance use programs at leading Illinois healthcare institutions including Rush, Michael Reese, Resurrection and Presence Behavioral Health. In addition to Dr. Rafeyan’s extensive medical experience, he is also a diplomate of the American Board of Psychiatry and Neurology and the American Society of Addiction Medicine. He is currently on the faculty at Northwestern University and an active member of the American Medical Association, American Psychiatry Association, Illinois Psychiatric Society and Illinois State Medical Society.
Alex-Matushek

Alex Matushek, PharmD, MBA (OPDC)

Clinical & Scientific Liaison

Roueen Rafeyan, MD is a paid consultant of Otsuka Pharmaceutical Development &
Commercialization, Inc.
Alex Matushek, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization,
Inc.


Registration

Related Resources